Literature DB >> 33128655

Tumefactive fibroinflammatory lesion of the maxilla: Successful resection and microvascular reconstruction after failed medical therapy.

James Higginson1, Omar Breik2, Heather Goodrum3, Adrian Warfield4, Timothy Bates4, Benjamin Rhodes5, Timothy Martin6.   

Abstract

Tumefactive fibroinflammatory lesions (TFILs) of the head and neck are rare and benign but locally aggressive lesions. The etiology and pathogenesis of these lesions are unknown. Medical management is regarded the first line of treatment. Surgical management has been rarely reported for head and neck lesions. A 51-year-old female presented with a 6-month history of left facial swelling and pain that subsequently developed into progressive inframalar hollowing and asymmetry. Biopsies confirmed tumefactive fibroinflammatory lesion of the maxilla. Initial treatment with high-dose steroids led to temporary partial involution; however, symptoms progressed. Cyclophosphamide and then rituximab were commenced, with minimal response. Imaging showed progression toward the infratemporal fossa. The patient subsequently underwent a resection and microvascular free flap reconstruction This patient had a successful surgical outcome and resolution of serum inflammatory markers with no evidence of recurrence after 18-month follow-up. A multidisciplinary approach is crucial to ensure a pragmatic patient-specific management plan is developed. Surgical resection and reconstruction can be successful in these lesions and should be considered if medical therapy has failed.

Entities:  

Keywords:  IgG4-disease; Pseudotumors; Reconstructive surgery; Surgical management; Tumefactive fibroinflammatory disease

Mesh:

Year:  2020        PMID: 33128655     DOI: 10.1007/s10006-020-00914-y

Source DB:  PubMed          Journal:  Oral Maxillofac Surg        ISSN: 1865-1550


  13 in total

Review 1.  IgG4-related disease.

Authors:  John H Stone; Yoh Zen; Vikram Deshpande
Journal:  N Engl J Med       Date:  2012-02-09       Impact factor: 91.245

Review 2.  Consensus statement on the pathology of IgG4-related disease.

Authors:  Vikram Deshpande; Yoh Zen; John Kc Chan; Eunhee E Yi; Yasuharu Sato; Tadashi Yoshino; Günter Klöppel; J Godfrey Heathcote; Arezou Khosroshahi; Judith A Ferry; Rob C Aalberse; Donald B Bloch; William R Brugge; Adrian C Bateman; Mollie N Carruthers; Suresh T Chari; Wah Cheuk; Lynn D Cornell; Carlos Fernandez-Del Castillo; David G Forcione; Daniel L Hamilos; Terumi Kamisawa; Satomi Kasashima; Shigeyuki Kawa; Mitsuhiro Kawano; Gregory Y Lauwers; Yasufumi Masaki; Yasuni Nakanuma; Kenji Notohara; Kazuichi Okazaki; Ji Kon Ryu; Takako Saeki; Dushyant V Sahani; Thomas C Smyrk; James R Stone; Masayuki Takahira; George J Webster; Motohisa Yamamoto; Giuseppe Zamboni; Hisanori Umehara; John H Stone
Journal:  Mod Pathol       Date:  2012-05-18       Impact factor: 7.842

Review 3.  Tumefactive fibroinflammatory lesion of the head and neck originating in the infratemporal fossa.

Authors:  P C Patel; P K Pellitteri; D P Vrabec; M Szymanski
Journal:  Am J Otolaryngol       Date:  1998 May-Jun       Impact factor: 1.808

Review 4.  Diagnostic Approach to the Complexity of IgG4-Related Disease.

Authors:  John H Stone; Pilar Brito-Zerón; Xavier Bosch; Manuel Ramos-Casals
Journal:  Mayo Clin Proc       Date:  2015-07       Impact factor: 7.616

Review 5.  Tumefactive fibroinflammatory lesion of the head and neck: a management strategy.

Authors:  J F Laurenzo; S M Graham
Journal:  Ear Nose Throat J       Date:  1995-02       Impact factor: 1.697

6.  Tumefactive fibro-inflammatory lesions of the head and neck.

Authors:  L E Wold; L H Weiland
Journal:  Am J Surg Pathol       Date:  1983-07       Impact factor: 6.394

7.  Tumefactive fibroinflammatory lesion successfully treated with Rituximab.

Authors:  Jessica L Bishop; Locke J Bryan; Natasha M Savage; J Kenneth Byrd
Journal:  Intractable Rare Dis Res       Date:  2019-05

8.  The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease.

Authors:  Zachary S Wallace; Ray P Naden; Suresh Chari; Hyon Choi; Emanuel Della-Torre; Jean-Francois Dicaire; Phil A Hart; Dai Inoue; Mitsuhiro Kawano; Arezou Khosroshahi; Kensuke Kubota; Marco Lanzillotta; Kazuichi Okazaki; Cory A Perugino; Amita Sharma; Takako Saeki; Hiroshi Sekiguchi; Nicolas Schleinitz; James R Stone; Naoki Takahashi; Hisanori Umehara; George Webster; Yoh Zen; John H Stone
Journal:  Arthritis Rheumatol       Date:  2019-12-02       Impact factor: 10.995

9.  Inflammatory Pseudotumor of the Temporal Bone: A Case Series.

Authors:  Timothy E Ortlip; Virginia E Drake; Prashant Raghavan; John C Papadimitriou; Neil C Porter; David J Eisenman; Ronna Hertzano
Journal:  Otol Neurotol       Date:  2017-08       Impact factor: 2.311

10.  Tumefactive fibroinflammatory lesion presenting with head and neck fibrosclerosing lesions and orbital pseudotumors: a case report.

Authors:  Soichi Kusaka; Sho Nishimura; Fumi Kawakami; Chiho Ohbayashi; Yasuyuki Shibuya; Kentaro Iwata
Journal:  J Med Case Rep       Date:  2013-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.